114 related articles for article (PubMed ID: 10640296)
1. Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells.
Yea SS; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 2000 Feb; 292(2):597-605. PubMed ID: 10640296
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 1998 Dec; 287(3):1105-12. PubMed ID: 9864299
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
Yun CH; Son CG; Jung U; Han SH
Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.
Yea SS; Jeong HS; Choi CY; Park KR; Oh S; Shin JG; Yun CH
Toxicol In Vitro; 2006 Oct; 20(7):1098-105. PubMed ID: 16531003
[TBL] [Abstract][Full Text] [Related]
5. Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.
Jan TR; Rao GK; Kaminski NE
Mol Pharmacol; 2002 Feb; 61(2):446-54. PubMed ID: 11809870
[TBL] [Abstract][Full Text] [Related]
6. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.
Paliogianni F; Raptis A; Ahuja SS; Najjar SM; Boumpas DT
J Clin Invest; 1993 Apr; 91(4):1481-9. PubMed ID: 8473495
[TBL] [Abstract][Full Text] [Related]
7. Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.
Herring AC; Kaminski NE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1156-63. PubMed ID: 10565837
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
9. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
10. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
Jabado N; Le Deist F; Fisher A; Hivroz C
Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
[TBL] [Abstract][Full Text] [Related]
11. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
Ouyang Y; Hwang SG; Han SH; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):676-83. PubMed ID: 9547358
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-4 production in activated T cells via the downregulation of AP-1/NF-AT activation by N-lauroyl-D-erythro-sphingosine and N-lauroyl-D-erythro-C20-sphingosine.
Park J; Kim SH; Li Q; Chang YT; Kim TS
Biochem Pharmacol; 2006 Apr; 71(8):1229-39. PubMed ID: 16448625
[TBL] [Abstract][Full Text] [Related]
13. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
14. Increased IL-2 production in T cells by xanthohumol through enhanced NF-AT and AP-1 activity.
Choi JM; Kim HJ; Lee KY; Choi HJ; Lee IS; Kang BY
Int Immunopharmacol; 2009 Jan; 9(1):103-7. PubMed ID: 19019318
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids inhibit the activation of ERK MAPK in PMA/Io-stimulated mouse splenocytes.
Faubert Kaplan BL; Kaminski NE
Int Immunopharmacol; 2003 Oct; 3(10-11):1503-10. PubMed ID: 12946447
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of interleukin-4 production via NF-AT/AP-1 activation in T cells by biochanin A, a phytoestrogen and its metabolites.
Park J; Chung SW; Kim SH; Kim TS
Toxicol Appl Pharmacol; 2006 May; 212(3):188-99. PubMed ID: 16169028
[TBL] [Abstract][Full Text] [Related]
19. Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol.
Jan TR; Kaminski NE
J Leukoc Biol; 2001 May; 69(5):841-9. PubMed ID: 11358994
[TBL] [Abstract][Full Text] [Related]
20. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
